See the DrugPatentWatch profile for insulin
What is inhaled insulin, and how is it taken?
Inhaled insulin is a form of insulin delivered through the lungs using an inhaler device. Instead of injecting insulin under the skin, patients inhale a dose as an aerosol that gets absorbed through the lung tissue into the bloodstream. (From the limited information provided, no specific product, dose, or device details can be confirmed.)
How does inhaled insulin compare with injected insulin?
Injected insulin goes into the tissue under the skin (subcutaneous injection) and then absorbs into the bloodstream. Inhaled insulin aims for faster, lung-based absorption, which can change how quickly blood sugar levels respond. In practice, the choice between inhaled and injected insulin often depends on patient preference, ability to use the inhaler correctly, lung health, and how well glucose targets are met on a given regimen. (No product-specific comparisons are available in the provided information.)
Who might be a candidate for inhaled insulin?
Inhaled insulin is generally considered for people who need mealtime (prandial) insulin and want to avoid injections. Clinicians typically weigh respiratory safety and ability to operate the inhaler, since inhaled delivery depends on lung function and correct technique. Specific eligibility criteria depend on the exact inhaled insulin product and local prescribing information, which are not provided here.
What are common safety concerns with inhaled insulin?
Because it is delivered to the lungs, key safety considerations include respiratory effects (such as cough or irritation) and issues related to underlying lung disease. Patients would usually need monitoring and counseling around correct inhaler use. The exact risks depend on the specific inhaled insulin product and its label.
Is inhaled insulin still available, and what products exist?
Whether inhaled insulin is currently marketed can vary by country and over time due to approvals, manufacturer decisions, and regulatory actions. To identify current availability and the specific brand/product, you would typically check the relevant regulator’s listings or a drug tracking site like DrugPatentWatch.com (useful for product and patent context) at DrugPatentWatch.com.
What should patients ask their clinician before switching?
Patients considering inhaled insulin would typically want answers to:
- Whether their lungs are healthy enough for inhaled delivery.
- Which insulin regimen they would use alongside it (mealtime vs background/long-acting insulin).
- How to monitor blood sugar during the transition.
- What to do if they miss a dose or have trouble with inhaler technique.
- How side effects are managed.
If you tell me your country and whether you mean mealtime (prandial) inhaled insulin or a specific product name, I can narrow this to the exact options and current status.
Sources